Division 3.6.2.2.6 Some important factors which may be taken into consideration, when assessing the overall level of concern are:
United Kingdom
- (a)
tumour type and background incidence;
- (b)
multi-site responses;
- (c)
progression of lesions to malignancy;
- (d)
reduced tumour latency;
- (e)
whether responses are in single or both sexes;
- (f)
whether responses are in a single species or several species;
- (g)
structural similarity to a substance(s) for which there is good evidence of carcinogenicity;
- (h)
routes of exposure;
- (i)
comparison of absorption, distribution, metabolism and excretion between test animals and humans;
- (j)
the possibility of a confounding effect of excessive toxicity at test doses;
- (k)
mode of action and its relevance for humans, such as cytotoxicity with growth stimulation, mitogenesis, immunosuppression, mutagenicity.
Mutagenicity: it is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects.